Nevertheless, another study has identified a unique CD8+T-cell blood/tumor-shared subpopulation in melanoma patients with high levels of oxidative phosphorylation, which is correlated with immune checkpoint inhibitor (ICI) resistance in melanoma patients. This evidence concerns the gene CD8A and neoplasm.